“EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA: Empiric Glycopeptide Use in Neutropenic Fever”. 2022. Mediterranean Journal of Hematology and Infectious Diseases 14 (1): e2022039. https://doi.org/10.4084/MJHID.2022.039.